Active — Not RecruitingNot Applicable

Molecular Epidemiology of Enteroviruses Detected at the Virology Laboratory of Brest University Hospital During the Period 2018-2024: Retrospective Analysis of an Atypical Meningitis Epidemic in 2024 (BrEcho9Men)

France270 participantsStarted 2025-03-01

Plain-language summary

This study is being done to learn more about enterovirus infections detected in the cerebrospinal fluid of patients at CHU de Brest. Researchers will analyze medical records and laboratory data collected between 2018 and 2024. They will look at how these infections present in patients, and whether a specific virus type, called Echo-9, may be associated with different clinical features or represent an emerging variant.

Who can participate

Age range0 Days – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Cerebrospinal fluid (CSF) sample positive for enterovirus by RT-PCR between January 1, 2018 and December 31, 2024 , performed at the virology laboratory of CHU de Brest. * No documented opposition to the use of medical data for research purposes. Exclusion Criteria: * Patients under legal protection (guardianship, curatorship, etc.) * Refusal to participate in the study

What they're measuring

Phylogenetic analysis of Echo-9 strains detected between 2018 and 2024

Timeframe: January 1, 2018 to December 31, 2024

Trial details

NCT IDNCT06922474

SponsorUniversity Hospital, Brest

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-10-31

View on ClinicalTrials.gov More Enterovirus Infections trials